Thursday, March 7, 2019

Purdue Pharma Sued Over Opioid Profiting

Originally published by John Curiel.

Litigation was recently announced against various opioid manufacturers and distributors, including Purdue Pharmaceuticals.

About the Opioid Lawsuit

According to Kusi News, the San Diego city attorney announced a federal lawsuit against several opioid manufacturers, including Purdue Pharma, and several opioid distributors, for profiting from and exacerbating the country’s opioid crisis.

The suit is intended to force the companies to fund rehabilitation and drug education programs in response to opioid abuse in the city. Further legal action is to be initiated against the Sackler family, owners of Purdue Pharma, for violation of the RICO Act.

Opioid named in the suit include AmerisourceBergen Corporation, Cardinal Health Inc., and the McKesson Corporation.

Information on the Opioid Crisis

  • According to the National Institute on Drug Abuse, more than 130 people die each day due to opioid overdose.
  • Between 21 and 29 percent of patients prescribed opioids for chronic pain misuse them.
  • Around 80 percent of heroin users first misused prescription opioids.
  • In 45 states, opioid overdoses increased 30 percent from July 2016 to September 2017.

Contact an Experienced Drug Litigation Attorney

If you or a loved one has been the victim of a dangerous pharmaceutical drug or medical device, you may be entitled to compensation. You deserve dynamic representation from a law firm with the resources necessary to take on the pharmaceutical companies. Thomas J. Henry has a track record of helping clients receive record-breaking verdicts, settlements, and judgments.

Our firm has offices in Corpus ChristiSan Antonio, Austin, and Houston, serving clients across Texas and nationwide. Call us today for a free case review — attorneys are available 24/7, nights and weekends.

 

The post Purdue Pharma Sued Over Opioid Profiting appeared first on ThomasJHenry.

Curated by Texas Bar Today. Follow us on Twitter @texasbartoday.



from Texas Bar Today https://ift.tt/2Us6NDG
via Abogado Aly Website

No comments:

Post a Comment